Sant Joan de Deu Health Park
If you are the contact person for this centre and you wish to make any changes, please contact us.
Miguel Servet Senior Researcher at the Teaching, Research and Innovation Unit of the Parc Sanitari Sant Joan de Déu, member of the Department of Psychiatry at Warneford Hospital-University of Oxford (UK) and member of Spain's Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP)
Psychiatrist and principal researcher at Parc Sanitari Sant Joan de Deu and Fundació de Recerca Sant Joan de Deu and secretary of the Spanish Society of Psychedelic Medicine
Research involving more than 200 patients with depression, whose symptoms had not improved after NHS talk therapy shows that those who took part in eight group sessions of mindfulness-based cognitive therapy saw their depressive symptoms reduced, compared with those who received treatment as usual. The study is published in The Lancet Psychiatry.
A dose of psilocybin—a hallucinogenic substance—administered to groups of 3 or 4 people suffering from cancer and depression may help reduce their depressive symptoms, according to a clinical trial conducted in the United States. The study involved 30 patients who also received individual and group therapeutic support. In another article, also published in the journal Cancer, the authors examine how the study participants perceived the therapy.